在初始剂量设计中,根据度-时间曲线对康明的目标区域的评估:回顾性队列研究
Moeko Iida1,2, Yasuhiro Horita1,2,3, Minami Asaoka1,2
1Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8602, Japan.
The Journal of antimicrobial chemotherapy
|July 19, 2024
概括
监测度-时间曲线 (AUC) 下的非稳定状态区域和谷底水平至关重要. 确定值可以帮助患者预防急性损伤 (AKI).
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 建立了以度-时间曲线 (AUC) 下面面积为指导的万科米辛剂量,但非平稳状态AUC的目标范围仍在争论中.
- 急性损伤 (AKI) 是万科米辛治疗的一个重大问题.
研究的目的:
- 为了确定非平稳状态的万科米辛AUC (1日和2日) 和低谷值的药理学参数值.
- 为了确定与万科米辛的管理相关的AKI的独立风险因素.
- 为了提供更安全的初始万科米辛剂量策略.
主要方法:
- 一个回顾性队列研究,涉及住院患者接受治疗的vancomycin.
- 确定非平稳状态AUCs (1日和2日) 和初始低谷值.
- 单变量和多变量逻辑回归分析以确定AKI风险因素.
主要成果:
- 预测AKI的值:AUC0-24h (456.6毫克·小时/升),AUC24-48h (554.8毫克·小时/升),AUC0-48h (1080.8毫克·小时/升) 和最低水平 (14.0微克/毫升).
- 独立的AKI风险因素包括第二天AUC≥554.8 mg·h/L,皮佩拉西林/塔扎巴克坦和利尿剂.
结论:
- 在万科米辛治疗期间,已建立非平稳状态AUC和初始低谷值的值.
- 强调监测AUC和低谷水平的重要性,以最大限度地降低AKI风险.
相关概念视频
Drug Concentration Versus Time Correlation
710
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
710
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
234
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
234
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
86
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
86
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
452
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
452


